Inventor · disambiguated record
John N. Vournakis
Also filed as: VOURNAKIS JOHN · VOURNAKIS JOHN N
46 granted patents·18 pending applications·1,531 citations·filing 1991–2024
99Inventor score
Files withMARINEPOLYMER TECH INC27MARINE POLYMER TECH INC10VOURNAKIS JOHN N8MARINE POLYMER TECHNOLOGIES4FINKIELSZTEIN SERGIO3
Top patents by PatentIndex Score
64 records- 0198US6864245B2Biocompatible poly-β-1→4-N-acetylglucosamineMARINEPOLYMER TECH INC·Filed 2003·Granted Mar 8, 2005·86 cites·22 claims
- 0297US6743783B1Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamineMARINEPOLYMER TECH INC·Filed 2001·Granted Jun 1, 2004·42 cites·5 claims
- 0397US5686115APoly-β-1→4-N-acetylucosamine copolymer composition with collagenMARINEPOLYMER TECH INC·Filed 1995·Granted Nov 11, 1997·120 cites·20 claims
- 0496US6630459B2Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamineMARINE POLYMERS TECHNOLOGIES·Filed 2001·Granted Oct 7, 2003·45 cites·5 claims
- 0596US5858350AMethods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy systemMARINE POLYMER TECHNOLOGIES·Filed 1995·Granted Jan 12, 1999·110 cites·18 claims
- 0695US7115588B2Methods for treating a breach or puncture in a blood vesselMARINEPOLYMER TECH INC·Filed 2002·Granted Oct 3, 2006·46 cites·19 claims
- 0795US6686342B2Bicompatible poly-β-1→4-N-acetylglucosamineMARINEPOLYMER TECH INC·Filed 2003·Granted Feb 3, 2004·28 cites·44 claims
- 0895US6599720B2Methods for making poly-β-1→4-N-acetylglucosamineMARINE POLYMER TECHNOLOGIES·Filed 2001·Granted Jul 29, 2003·33 cites·2 claims
- 0994US7285266B2Cell-polymer fiber compositions and uses thereofMARINEPOLYMER TECH INC·Filed 2004·Granted Oct 23, 2007·47 cites·12 claims
- 1094US6265548B1Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescenceUS HEALTH·Filed 2000·Granted Jul 24, 2001·52 cites·9 claims
- 1193US9931377B2Cell expressing complexes of IL-15 and IL-15RalphaPAVLAKIS GEORGE N·Filed 2008·Granted Apr 3, 2018·23 cites·23 claims
- 1293US8481512B2Compositions and methods for modulation of vascular structure and/or functionVOURNAKIS JOHN N·Filed 2010·Granted Jul 9, 2013·15 cites·28 claims
- 1393US7041657B2Compositions and methods for modulation of vascular structure and/or functionMARINEPOLYMER TECH INC·Filed 2001·Granted May 9, 2006·34 cites·27 claims
- 1493US6649599B2Methods and compositions for poly-β-1-4-N-acetylglucosamine cell therapy systemMARINEPOLYMER TECH INC·Filed 2001·Granted Nov 18, 2003·30 cites·4 claims
- 1593US6610668B2Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy systemMARINE POLYMERS TECHNOLOGIES·Filed 2001·Granted Aug 26, 2003·29 cites·2 claims
- 1693US5635493AMethods and compositions for poly-β-1-4-N-acetylglucosamine chemotherapeuticsMARINEPOLYMER TECH INC·Filed 1995·Granted Jun 3, 1997·71 cites·16 claims
- 1792US8992453B2Vascular access preservation in hemodialysis patientsVOURNAKIS JOHN N·Filed 2012·Granted Mar 31, 2015·17 cites·20 claims
- 1892US8858964B2Anti-bacterial applications of poly-N-acetylglucosamine nanofibersVOURNAKIS JOHN N·Filed 2011·Granted Oct 14, 2014·14 cites·34 claims
- 1992US5846952AMethods and compositions for poly-β-1-4-N-acetylglucosamine drug deliveryMARINEPOLYMER TECH INC·Filed 1995·Granted Dec 8, 1998·61 cites·18 claims
- 2092US5624679AMethods and compositions for poly-β-1-4-N-acetylglucosamine biological barriersMARINEPOLYMER TECH INC·Filed 1995·Granted Apr 29, 1997·63 cites·14 claims
- 2191US9139664B2Hemostatic compositions and therapeutic regimensMARINEPOLYMER TECH INC·Filed 2013·Granted Sep 22, 2015·10 cites·41 claims
- 2291US8859528B2Compositions and methods for modulation of vascular structure and/or functionMARINEPOLYMER TECH INC·Filed 2013·Granted Oct 14, 2014·9 cites·36 claims
- 2391US8802083B2Method of making platelet and poly-beta-1,4-N-acetylglucosamine fiber compositionsVOURNAKIS JOHN N·Filed 2012·Granted Aug 12, 2014·12 cites·44 claims
- 2491US6063911AMethods and compositions for treatment of cell proliferative disordersMARINEPOLYMER TECH INC·Filed 1998·Granted May 16, 2000·94 cites·35 claims
- 2591US5623064APoly-β-1→-4-N-acetylglucosamineMARINEPOLYMER TECH INC·Filed 1994·Granted Apr 22, 1997·78 cites·36 claims
- 2690US9320653B2Hemostatic compositions and uses thereforMARINEPOLYMER TECH INC·Filed 2014·Granted Apr 26, 2016·9 cites·25 claims
- 2789US9198928B2Anti-bacterial applications of poly-N-acetylglucosamine nanofibersMARINEPOLYMER TECH INC·Filed 2014·Granted Dec 1, 2015·8 cites·63 claims
- 2889US6027881AMutant Aequorea victoria fluorescent proteins having increased cellular fluorescenceUS HEALTH·Filed 1996·Granted Feb 22, 2000·77 cites·21 claims
- 2988US8871247B2Hemostatic compositions and therapeutic regimensFINKIELSZTEIN SERGIO·Filed 2008·Granted Oct 28, 2014·8 cites·35 claims
- 3088US8152750B2Vascular access preservation in hemodialysis patientsVOURNAKIS JOHN N·Filed 2004·Granted Apr 10, 2012·25 cites·34 claims
- 3187US10206938B2Anti-bacterial applications of poly-N-acetylglucosamine nanofibersMARINE POLYMER TECH INC·Filed 2017·Granted Feb 19, 2019·4 cites·20 claims
- 3287US9642871B2Anti-bacterial applications of poly-N-acetylglucosamine nanofibersMARINE POLYMER TECH INC·Filed 2015·Granted May 9, 2017·4 cites·41 claims
- 3387US5622834AMethod of isolating poly-β-1-4-N-acetylglucosamine from microalgal cultureMARINEPOLYMER TECH INC·Filed 1993·Granted Apr 22, 1997·57 cites·18 claims
- 3486US9139663B2Hemostatic compositions and therapeutic regimensMARINEPOLYMER TECH INC·Filed 2013·Granted Sep 22, 2015·5 cites·35 claims
- 3584US7931637B2Hemostatic compositions and uses thereforMARINEPOLYMER TECH INC·Filed 2003·Granted Apr 26, 2011·31 cites·33 claims
- 3683US10335460B2IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditionsNOVARTIS AG·Filed 2015·Granted Jul 2, 2019·4 cites·19 claims
- 3783US8835408B2Hemostatic compositions and uses thereforVOURNAKIS JOHN N·Filed 2011·Granted Sep 16, 2014·12 cites·43 claims
- 3880US5219749AProcess for isolating and preparing purified chitin deacetylaseINST MOLECULAR BIOLOGY & BIOTE·Filed 1991·Granted Jun 15, 1993·68 cites·4 claims
- 3978US6399328B1Methods and compositions for diagnosis and treatment of breast cancerMUSC FOUND FOR RES DEV·Filed 1998·Granted Jun 4, 2002·39 cites·23 claims
- 4077US2025108092A1Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 4176US8486033B2Application of polymeric materials to screens to facilitate hemostasis and wound healingORGILL DENNIS P·Filed 2010·Granted Jul 16, 2013·5 cites·27 claims
- 4274US2023157971A1Compositions and methods for nanopolymer-based nucleic acid deliveryMARINE POLYMER TECH INC·Filed 2022·Application pending·0 cites
- 4373US10383971B2Hemostatic compositions and therapeutic regimensMARINE POLYMER TECH INC·Filed 2015·Granted Aug 20, 2019·1 cites·27 claims
- 4469US2009318383A1Compositions and methods for modulation of vascular structure and/or functionMARINE POLYMER TECHNOLOGIES·Filed 2009·Application pending·0 cites
- 4568US10561677B2Anti-bacterial applications of poly-N-acetylglucosamine nanofibersMARINE POLYMER TECH INC·Filed 2018·Granted Feb 18, 2020·0 cites·31 claims
- 4667US2009247738A1Biocompatible poly-beta-1-4-n-acetylglucosamineMARINEPOLYMER TECH INC·Filed 2009·Application pending·0 cites
- 4766US2015118281A1Compositions and Methods For Modulation of Vascular Structure and/or FunctionMARINEPOLYMER TECH INC·Filed 2014·Application pending·0 cites
- 4865US8834516B2Methods and apparatus for a manual vascular compression deviceFINKIELSZTEIN SERGIO·Filed 2006·Granted Sep 16, 2014·5 cites·4 claims
- 4965US2018360868A1Treatment of disease with poly-n-acetylglucosamine nanofibersMARINE POLYMER TECH INC·Filed 2017·Application pending·0 cites
- 5063US10765698B2Treatment of disease with poly-N-acetylglucosamine nanofibersMARINE POLYMER TECH INC·Filed 2017·Granted Sep 8, 2020·0 cites·37 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John N. Vournakis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →